SEC Form 4 · accession 0000899243-19-006155
REPLIGEN CORP · RGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jon Snodgres
Officer — Chief Financial Officer
Period of report
Mar 1, 2019
Accepted (ET)
Mar 5, 2019 · 5:34 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000730272
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 1, 2019 | A | 4,700 | $0.00 | A | 29,646 | D | |
| Common StockF3 | Mar 5, 2019 | S | 2,645 | $58.52 | D | 27,001 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares awarded pursuant to Performance Share Units ("PSUs"). The Compensation Committee authorized the issuance of the underlying shares based upon the Issuer's achievement of pre-established performance criteria related to the filing of the 2018 Annual Report on Form 10-K, which was filed on March 1, 2019. These PSUs vested on March 1, 2019.
- F2Sale of 2,645 shares in the open market to cover tax liability resulting from the release of restricted stock units and PSUs.
- F3$58.52 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.28 to $58.97, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.